Company: ACBM
Filing Date: 2025-07-02
Form Type: 8-K
Source: 0001640334-25-001097
Chunk: 0

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-02
Form: 8-K
Item: Item 4.01
Chunk 0
---
Item 4.01 Change in Registrant’s Certifying Accountant

On June 30, 2025, the Company dismissed Prager Metis CPAs, LLC (“ Prager Metis”) as the Company’s independent registered public accounting firm. During the Company’s fiscal years ended December 31, 2024 and 2023 and the subsequent interim period from January 1, 2025 to the date of Prager Metis’ dismissal, there were no disagreements between the Company and Prager Metis on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Prager Metis, would have caused Prager Metis to make reference to the subject matter of such disagreements in connection with its audit reports on the Company’s financial statements. Prager Metis did not audit the Company’s financial statements for the years ended December 31, 2024 and 2023. Prager Metis’ report on the Company’s financial statements for the year ended December 31, 2022 included an explanatory paragraph as to the Company’s ability to continue as a going concern.

On June 30, 2025, the Company’s board of directors approved the engagement of KCCW Accountancy Corp. (“ KCCW”) as its independent registered accounting company. During the Company’s fiscal year ended December 31, 2024, and the subsequent interim period from January 1, 2025 to the date of this report, neither the Company nor anyone acting on its behalf consulted with KCCW regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company by KCCW that was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) or a reportable event (as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions) relating to the Company.

The Company has provided Prager Metis with a copy of the disclosures in this report and has requested that Prager Metis furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not Prager Metis agrees with the statements in this Item 4.01. A copy of this letter is filed as Exhibit 16.1 to this report.